Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Synlogic Inc
(NQ:
SYBX
)
3.400
USD
+0.240 (+7.59%)
Official Closing Price
Updated: 7:58 PM EDT, Apr 16, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,971,800
Open
3.000
Bid (Size)
3.130 (2)
Ask (Size)
3.400 (53)
Prev. Close
3.160
Today's Range
3.000 - 3.430
52wk Range
1.780 - 5.110
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Synlogic Announces Pricing of Public Offering of Common Stock
April 16, 2021
Synlogic (Nasdaq: SYBX) a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the pricing of its underwritten public offering of 10,000,000...
From
PR Newswire
Synlogic Announces Proposed Public Offering of Common Stock
April 15, 2021
Synlogic (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that it has commenced an underwritten public offering of its...
From
PR Newswire
Performance
YTD
+54.55%
+54.55%
1 Month
-18.66%
-18.66%
3 Month
-3.41%
-3.41%
6 Month
+69.15%
+69.15%
1 Year
+81.82%
+81.82%
More News
Read More
Synlogic Presents Data Demonstrating Activity of a Solid Oral Formulation of SYNB1618 at American College of Medical Genetics (ACMG) Annual Meeting
April 13, 2021
From
PR Newswire
Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting
April 10, 2021
From
PR Newswire
Synlogic to Present at Upcoming Virtual Banking and Industry Conferences
April 01, 2021
From
PR Newswire
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
March 25, 2021
From
PR Newswire
Synlogic Announces SYNB8802 Will Advance to Phase 1B Proof of Concept Study After Proof of Mechanism Demonstrated in Dietary Hyperoxaluria
March 24, 2021
From
PR Newswire
Synlogic Announces Fourth Quarter and Full Year 2020 Conference Call & Webcast
March 16, 2021
From
PR Newswire
Synlogic Announces Promotion of Dr. Caroline Kurtz to Chief Development Officer and Strengthening of Leadership Team
March 08, 2021
From
PR Newswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 25, 2021
Tags
Top Gainers
Pre/Market Outlook
ENOB
From
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 24, 2021
Tags
General
AMWL
RGNX
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.